Publications by authors named "Go Fujimoto"

Claim this Profile
O
Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study.
Hiroshi Nakase, Toshimitsu Fujii, Tadakazu Hisamatsu, Yasuo Suzuki, Mamoru Watanabe, Go Fujimoto

Gastro Hep Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan.
Tsutomu Yoshida, Go Ogura, Mikiko Tanabe, Takuo Hayashi, Chiho Ohbayashi, Go Fujimoto

Cancer Biol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a clinical prediction model for recurrence and mortality outcomes after Clostridioides difficile infection using a machine learning approach.
Daniel Ruzicka, Takayuki Kondo, Go Fujimoto, Andrew P Craig, Seok-Won Kim

Anaerobe· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study.
Rie Ueno, Shinichi Nishimura, Go Fujimoto, Dilinuer Ainiwaer

Curr Med Res Opin· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The disease burden of mucormycosis in Japan: results from a systematic literature review and retrospective database study.
Rie Ueno, Shinichi Nishimura, Go Fujimoto, Dilinuer Ainiwaer

Curr Med Res Opin· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan - a retrospective database study.
Rie Ueno, Shinichi Nishimura, Go Fujimoto, Yi Piao, Katsuto Takenaka

Curr Med Res Opin· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Adherence/Persistence and Demographics of Japanese Dyslipidemia Patients on Statin-Ezetimibe as a Separate Pill Combination Lipid-Lowering Therapy　- An Observational Pharmacy Claims Database Study.
Tatsuya Umeda, Ai Hayashi, Go Fujimoto, Yi Piao, Nobutomo Matsui

Circ J· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection.
Soichi Arakawa, Kazuya Kawahara, Motoshi Kawahara, Mitsuru Yasuda, Go Fujimoto

J Infect Chemother· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections.
Hiroshige Mikamo, Kazuteru Monden, Yoshiaki Miyasaka, Tetsuya Horiuchi, Go Fujimoto

J Infect Chemother· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016.
Daniel J Ruzicka, Jumpei Tetsuka, Go Fujimoto, Tatsuya Kanto

BMC Infect Dis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients.
Hiroshige Mikamo, Norihiro Aoyama, Miyuki Sawata, Go Fujimoto, Mary Beth Dorr

J Infect Chemother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study.
Hiromitsu Kumada, Yoshiyuki Suzuki, Yoshiyasu Karino, Kazuaki Chayama, Norifumi Kawada, Go Fujimoto

J Gastroenterol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies.
Hiromitsu Kumada, Satoshi Mochida, Fumitaka Suzuki, Kazuaki Chayama, Yoshiyasu Karino, Go Fujimoto

J Gastroenterol Hepatol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5 mg in Japanese subjects with essential hypertension: two randomized, controlled trials.
Hiromi Rakugi, Takuya Tsuchihashi, Kazuyuki Shimada, Hirotaka Numaguchi, Chisato Nishida, Go Fujimoto

Hypertens Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes.
Kenji Nonaka, Taro Kakikawa, Asako Sato, Kotoba Okuyama, Go Fujimoto

Diabetes Res Clin Pract· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of particulate matter on daily mortality in 13 Japanese cities.
Takashi Omori, Go Fujimoto, Isao Yoshimura, Hiroshi Nitta, Masaji Ono

J Epidemiol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis